Accretion Nutraveda
BSE: ANL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Accretion Nutraveda's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Accretion Nutraveda Limited is an Indian company operating within the wellness and nutraceutical sectors. It focuses on the manufacturing, marketing, and distribution of health supplements and herbal products designed for preventive healthcare and lifestyle management.
Business Model
The company generates revenue by sourcing natural ingredients and developing specialized formulations for the fast-moving consumer goods and healthcare markets. It leverages a diversified portfolio of health-centric products to cater to the growing demand for wellness solutions.
Management Commentary
The company is currently positioning itself as a small-cap entity focused on capturing growth within the expanding Indian wellness market following its corporate rebranding.
Growth Outlook
Growth is expected to be driven by the increasing consumer demand for preventive healthcare and the company's strategic focus on the fast-moving consumer goods and wellness space.
Key Risks
- Regulatory Compliance. The nutraceutical and wellness sector is subject to stringent and evolving food safety and health regulations in India.
- Market Competition. The company faces intense competition from both established pharmaceutical players and new entrants in the fragmented wellness market.
- Supply Chain Volatility. Dependence on the sourcing of natural ingredients exposes the company to price fluctuations and quality consistency risks.
- Brand Perception. As a company focused on health supplements, any negative publicity regarding product efficacy or safety could significantly impact brand equity.
Start your research today
Unlock AI insights, financials, peers and live data on Accretion Nutraveda and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Accretion NutravedaANL | ₹204 Cr | — | — | — | 20.0% | — | — | — |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Accretion Nutraveda
BSE: ANL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Accretion Nutraveda's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Accretion Nutraveda Limited is an Indian company operating within the wellness and nutraceutical sectors. It focuses on the manufacturing, marketing, and distribution of health supplements and herbal products designed for preventive healthcare and lifestyle management.
Business Model
The company generates revenue by sourcing natural ingredients and developing specialized formulations for the fast-moving consumer goods and healthcare markets. It leverages a diversified portfolio of health-centric products to cater to the growing demand for wellness solutions.
Management Commentary
The company is currently positioning itself as a small-cap entity focused on capturing growth within the expanding Indian wellness market following its corporate rebranding.
Growth Outlook
Growth is expected to be driven by the increasing consumer demand for preventive healthcare and the company's strategic focus on the fast-moving consumer goods and wellness space.
Key Risks
- Regulatory Compliance. The nutraceutical and wellness sector is subject to stringent and evolving food safety and health regulations in India.
- Market Competition. The company faces intense competition from both established pharmaceutical players and new entrants in the fragmented wellness market.
- Supply Chain Volatility. Dependence on the sourcing of natural ingredients exposes the company to price fluctuations and quality consistency risks.
- Brand Perception. As a company focused on health supplements, any negative publicity regarding product efficacy or safety could significantly impact brand equity.
Start your research today
Unlock AI insights, financials, peers and live data on Accretion Nutraveda and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026